Burns Matteson Capital Management LLC Has $215,000 Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Burns Matteson Capital Management LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 6.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 730 shares of the biotechnology company’s stock after buying an additional 46 shares during the period. Burns Matteson Capital Management LLC’s holdings in Axon Enterprise were worth $215,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Avantax Advisory Services Inc. grew its holdings in Axon Enterprise by 0.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after acquiring an additional 40 shares during the period. Brookstone Capital Management raised its holdings in Axon Enterprise by 5.1% in the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock worth $263,000 after purchasing an additional 41 shares during the period. Envestnet Portfolio Solutions Inc. grew its stake in Axon Enterprise by 1.1% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $1,033,000 after acquiring an additional 43 shares during the period. UMB Bank n.a. increased its stake in Axon Enterprise by 11.0% during the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after purchasing an additional 44 shares in the last quarter. Finally, Rise Advisors LLC increased its position in shares of Axon Enterprise by 49.0% during the first quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock worth $45,000 after acquiring an additional 47 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ AXON traded up $8.84 on Tuesday, reaching $295.00. The stock had a trading volume of 1,068,781 shares, compared to its average volume of 498,095. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55. The company has a market cap of $22.26 billion, a P/E ratio of 86.26, a price-to-earnings-growth ratio of 6.59 and a beta of 0.95. The firm has a fifty day moving average of $296.14 and a two-hundred day moving average of $294.62. Axon Enterprise, Inc. has a 1-year low of $175.59 and a 1-year high of $329.87.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.95 by $0.20. The business had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. Axon Enterprise’s revenue was up 34.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.51 earnings per share. On average, equities research analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current year.

Insiders Place Their Bets

In related news, Director Julie A. Cullivan sold 993 shares of the stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the sale, the director now owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Julie A. Cullivan sold 993 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $281.72, for a total value of $279,747.96. Following the completion of the transaction, the director now directly owns 4,553 shares in the company, valued at approximately $1,282,671.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Julie A. Cullivan sold 478 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $286.04, for a total transaction of $136,727.12. Following the sale, the director now directly owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock worth $27,684,677 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. JMP Securities restated a “market outperform” rating and issued a $375.00 target price on shares of Axon Enterprise in a research note on Tuesday, May 7th. Morgan Stanley increased their price objective on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. JPMorgan Chase & Co. upped their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Finally, Needham & Company LLC restated a “buy” rating and set a $400.00 price objective on shares of Axon Enterprise in a research note on Tuesday, May 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $342.54.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.